Durvalumab with bevacizumab and transarterial chemoembolisation for treating locally advanced hepatocellular carcinoma [ID3944]

  • Awaiting development
  • GID-TA10911
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes